Mode VC

Paul Hoerbelt

Director, Biotechnologies atResearch Corporation TechnologiesTucson
Full bioFirm profile

Paul Hoerbelt is Director of Biotechnologies at Research Corporation Technologies, focusing on life science tools and therapeutics. He previously worked at Illumina Ventures and L.E.K. Consulting.

What Paul can write

Writes checks of$250K to $10M
Comes in atPre-seed, Seed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Research Corporation Technologies writes $250K to $10M checks, larger than 33% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Research Corporation Technologies.

Career

  1. Albany Medical College · Graduate Student Researcher
    2009-2015
  2. Stanford University · Postdoctoral Scholar
    2015-2020
  3. L.E.K. Consulting · Sr. Life Sciences Specialist
    2020-2021
  4. Illumina Ventures · Associate
    2021-2023
  5. Research Corporation Technologies · Director, Biotechnologies
    Now

Focus

life science toolstherapeuticsbiotechnologiesinvestmentbusiness growth

Education

Stanford University Graduate School of Business, Ignite Certificate Program in InnovationAlbany Medical College, Ph.D., Neuropharmacology and NeuroscienceState University of New York (SUNY) at Albany, B.S., Biology and Philosophy (dual major)

Also at Research Corporation Technologies

Shaun A. KirkpatrickPresident, Biotechnologies
Brad MorieSenior Director, Biotechnologies
Chad W. SouvignierVice President
David A. WiersmaSenior Associate
William KellyAssociate

Partners like Paul

At firms with a similar stage, sector and check size.

Ann DeWitt
Ann DeWittGeneral Partner, The Engine
Aryeh GanzManaging Partner, Cornucopian Capital
Jack W. Lasersohn
Jack W. LasersohnGeneral Partner, The Vertical Group
Brad Corona
Brad CoronaManaging Director, Vertical Venture Partners
Jamie RutledgeGeneral Partner, Bluelake
Carey Ng, PhD, MBAManaging Director, Mesa Verde Venture Partners

Alert me when Research Corporation Technologies is active

One email when Paul's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Paul Hoerbelt?

Paul Hoerbelt is Director of Biotechnologies at Research Corporation Technologies, focusing on life science tools and therapeutics. He previously worked at Illumina Ventures and L.E.K. Consulting.

How much does Paul Hoerbelt invest?

Paul Hoerbelt invests through Research Corporation Technologies, which writes checks of $250K to $10M at pre-seed, seed, series a.

How do I pitch Paul Hoerbelt?

A warm intro from a founder Research Corporation Technologies backed works best.

What did Paul Hoerbelt do before Research Corporation Technologies?

Graduate Student Researcher at Albany Medical College; Postdoctoral Scholar at Stanford University; Sr. Life Sciences Specialist at L.E.K. Consulting; Associate at Illumina Ventures.

Last updated 2026-10-15. Is this you? Ask for a correction.